Literature DB >> 16864226

Who is epidemiologically fathomable in the HIV/AIDS epidemic? Gender, sexuality, and intersectionality in public health.

Shari L Dworkin1.   

Abstract

This paper examines the shifting nature of contemporary epidemiological classifications in the HIV/AIDS epidemic. It first looks at assumptions that guide a discourse of vulnerability and circulate around risk categories. It then examines the underlying emphasis in public health on the popular frame of "vulnerable women" who acquire HIV through heterosexual transmission. Drawing on work on gender, sexuality, and intersectionality, the paper asks why a discourse of vulnerability is infused into discussions of heterosexually-active women's HIV risks but not those pertaining to heterosexually-active men's. The paper then moves to current surveillance categories that are hierarchically and differentially applied to women's and men's risks in the HIV epidemic. Here, the focus is on the way in which contemporary classifications allow for the emergence of the vulnerable heterosexually-active woman while simultaneously constituting lack of fathomability concerning bisexual and lesbian transmission risk. Lastly, theories of intersectionality, are used to examine current research on woman-to-woman transmission, and to suggest future more productive options.

Entities:  

Mesh:

Year:  2005        PMID: 16864226      PMCID: PMC4115794          DOI: 10.1080/13691050500100385

Source DB:  PubMed          Journal:  Cult Health Sex        ISSN: 1369-1058


  16 in total

1.  HIV prevalence, risk behaviors, and high-risk sexual and injection networks among young women injectors who have sex with women.

Authors:  Samuel R Friedman; Danielle C Ompad; Carey Maslow; Rebecca Young; Patricia Case; Sharon M Hudson; Theresa Diaz; Edward Morse; Susan Bailey; Don C Des Jarlais; Theresa Perlis; Amber Hollibaugh; Richard S Garfein
Journal:  Am J Public Health       Date:  2003-06       Impact factor: 9.308

Review 2.  HIV disease and AIDS in women: current knowledge and a research agenda.

Authors:  C A Hankins; M A Handley
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1992-10

Review 3.  Beyond the male condom: the evolution of gender-specific HIV interventions for women.

Authors:  Theresa M Exner; Shari L Dworkin; Susie Hoffman; Anke A Ehrhardt
Journal:  Annu Rev Sex Res       Date:  2003

4.  Violence, rape, and sexual coercion: everyday love in a South African township.

Authors:  K Wood; R Jewkes
Journal:  Gend Dev       Date:  1997-06

5.  Female ejaculation: perceived origins, the Grafenberg spot/area, and sexual responsiveness.

Authors:  C A Darling; J K Davidson; C Conway-Welch
Journal:  Arch Sex Behav       Date:  1990-02

Review 6.  Structural barriers and facilitators in HIV prevention: a review of international research.

Authors:  R G Parker; D Easton; C H Klein
Journal:  AIDS       Date:  2000-06       Impact factor: 4.177

7.  Sexually transmitted infections and risk behaviours in women who have sex with women.

Authors:  K Fethers; C Marks; A Mindel; C S Estcourt
Journal:  Sex Transm Infect       Date:  2000-10       Impact factor: 3.519

8.  Gender, sexuality, and HIV/AIDS: the what, the why, and the how.

Authors:  G R Gupta
Journal:  Can HIV AIDS Policy Law Rev       Date:  2000

9.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1992-12-18

10.  Who infects whom? HIV-1 concordance and discordance among migrant and non-migrant couples in South Africa.

Authors:  Mark N Lurie; Brian G Williams; Khangelani Zuma; David Mkaya-Mwamburi; Geoff P Garnett; Michael D Sweat; Joel Gittelsohn; Salim S Abdool Karim
Journal:  AIDS       Date:  2003-10-17       Impact factor: 4.177

View more
  36 in total

1.  Introduction to the Special Section on Bisexual Health: Can You See Us Now?

Authors:  Wendy B Bostwick; Brian Dodge
Journal:  Arch Sex Behav       Date:  2018-12-10

2.  The "new masculinity": addiction treatment as a reconstruction of gender in Puerto Rican evangelist street ministries.

Authors:  Helena Hansen
Journal:  Soc Sci Med       Date:  2011-08-03       Impact factor: 4.634

3.  "That's not me anymore": Resistance strategies for managing intersectional stigmas for women with substance use and incarceration histories.

Authors:  Alana J Gunn; Tina K Sacks; Alexis Jemal
Journal:  Qual Soc Work       Date:  2016-12-15

Review 4.  Theoretical Foundations of Research Focused on HIV Prevention Among Substance-Involved Women: A Review of Observational and Intervention Studies.

Authors:  Judith D Auerbach; Laramie R Smith
Journal:  J Acquir Immune Defic Syndr       Date:  2015-06-01       Impact factor: 3.731

5.  Condoms and Contexts: Profiles of Sexual Risk and Safety Among Young Heterosexually Active Men.

Authors:  N Tatiana Masters; Erin Casey; Blair Beadnell; Diane M Morrison; Marilyn J Hoppe; Elizabeth A Wells
Journal:  J Sex Res       Date:  2014-09-25

6.  Help seeking for cardiac symptoms: beyond the masculine-feminine binary.

Authors:  Paul M Galdas; Joy L Johnson; Myra E Percy; Pamela A Ratner
Journal:  Soc Sci Med       Date:  2010-03-20       Impact factor: 4.634

7.  The Role of Relationship Type, Risk Perception, and Condom Use in Middle Socioeconomic Status Black Women's HIV-prevention Strategies.

Authors:  Kia Caldwell; Allison Mathews
Journal:  J Black Sex Relatsh       Date:  2015

8.  Gendered aspects of perceived and internalized HIV-related stigma in China.

Authors:  Li Li; Chunqing Lin; Guoping Ji
Journal:  Women Health       Date:  2016-09-14

9.  What is in a label? Multiple meanings of 'MSM' among same-gender-loving Black men in Mississippi.

Authors:  Nhan Truong; Amaya Perez-Brumer; Melissa Burton; June Gipson; DeMarc Hickson
Journal:  Glob Public Health       Date:  2016-03-07

10.  The importance of masculinity and gender norms for understanding institutional responses to HIV testing and treatment strategies.

Authors:  Paul J Fleming; Shari L Dworkin
Journal:  AIDS       Date:  2016-01-02       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.